Back to results
US 12,611,432 B2Granted
Immunostimulatory bacteria for the treatment of cancer
AssigneeNorthwestern University
InventorsJonathan F. Anker, Praveen Thumbikat, Sarki A. Abdulkadir, Anthony J. Schaeffer
Life of this patent
Estimating the term…
Abstract
Provided herein are composition and methods for the treatment of cancer by the administration of uropathogenic bacteria. In particular, CP1 E. coli is administered for the treatment of prostate cancer.
Claims14
A composition comprising Escherichia coli (E. coli) strain CP1 bacteria (ATCC Patent Deposit #PTA-127513) that is genetically engineered to display one or more tumor-associated antigens.
Dependencies are inferred from the claim text.